Combination therapy with TiO2 nanoparticles and cisplatin enhances chemotherapy response in murine melanoma models.
R AdibzadehM S GolhinS SariH MohammadpourR KheirbakhshA MuhammadnejadS AmanpourM A MoosaviMarveh RahmatiPublished in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)
The combination of TiO2 NP with cisplatin enhances chemotherapy response in both in vitro and in vivo melanoma models. In addition, autophagy plays an essential role during sensitizing melanoma cells to chemotherapy.